ACTINIUM PHARMACEUTICALS INC
ATNMNYSE AMERICAN🏆 #3620 by market capEarnings Nov 13US Equity
$0.79▲ $0.02 (+2.97%)
🌙 After hours$0.79▼ 0.39%Regular close · extended-hours price shown1h—
24h▲ 3.0%
7d▲ 5.7%
14d▼ 5.5%
30d▼ 15.3%
1y▼ 48.2%
🏦Market Cap
$25M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
278.0x
Expensive
Otter Score
53
Weak
📊
Analyst Ratings
Price
$0.7931
Total
11
Raised
0
Lowered
0
Avg PT
$11.07
H / L
$24 / $4
| Institution | Action | Rating | Date |
|---|---|---|---|
Stephens & Co. | Reiterated | Overweight | 2026-03-31 |
HC Wainwright & Co. | Reiterated | Buy | 2025-06-24 |
Maxim Group | Reiterated | Buy | 2024-08-06 |
Cantor Fitzgerald | Reiterated | Overweight | 2024-04-30 |
B. Riley Securities | Reiterated | Buy | 2023-12-11 |
H.C. Wainwright | Reiterated | Buy | 2020-06-04 |
B. Riley FBR | Reiterated | Buy | 2018-07-12 |
Roth Capital | Reiterated | Buy | 2016-08-25 |
FBR Capital | Reiterated | Outperform | 2015-10-15 |
MLV & Co. | Reiterated | Buy | 2014-10-01 |
Canaccord Genuity | Reiterated | Buy | 2014-07-22 |
One row per institution, most recent rating